China · Investor

K2VC

Last cheque observed Apr 2026; 175 cheques on record.

Deploying nowNew fund $37M, Sept 2021VC firm

Pre-seedSeedSeries ATechnologyAdvanced ManufacturingNew Energy

Deploying now
57%of best year13cheques in 12 months, 175 on record
Since the last cheque213days00hrs00min00sec
Median round$7.0MRounds led0 of 175Sole investor63 roundsMostly inUnited States, 73%
Pitch K2VC

K2VC highlights

  1. 01

    13 cheques in the last 12 months

  2. 02

    Mostly Series A and Venture: 50% of its rounds

  3. 03

    Sole investor in 63 rounds, median $1.6M

What they do

K2VC focuses on early-stage investment, committed to advancing technological progress, industrial upgrading, innovation in business models, and the evolution of people's lifestyles.Translated from Chinese, from their own website
Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
Pre-seedSeedSeries ASeries BGrowthPre-IPO
Sectors
TechnologyAdvanced ManufacturingNew Energy
Based in
Chaoyang, China
Cold pitches
Accepted

The record

Every round we can evidence, newest first175 appearances

  1. 2026

    12 rounds

  2. Apr
    Collov LabsSeries A · US$23MWith 2 others
  3. Apr
    Aureka BiotechnologiesSeries A · US$35MWith 3 others
  4. Mar
    CosmoleapVentureUndisclosedSole investor
  5. Mar
    Noshi RoboticsSeries A$15MSole investor
  6. Mar
    ApollomicsDebt · US$2.0MWith 1 other
  7. Feb
    GluBio TherapeuticsVenture$30MWith 4 others
  8. Jan
    Qingbo ExplorationVentureUndisclosedWith 1 other
  9. Jan
    Fortitude BiomedicinesSeed · US$13MWith 1 other
  10. Jan
    Langsilicon TechnologySeed$12MWith 1 other
  11. Jan
    MindverseSeed · SG$20MWith 3 others
  12. Jan
    Startous fusionSeries A$143MWith 4 others
  13. Jan
    Weiyuan Synthetic BiotechnologyVenture$43MWith 2 others
  14. 2025

    14 rounds

  15. Nov
    Cornerstone RoboticsVenture · HK$200MWith 4 others
  16. Oct
    Shexu TechnologyVentureUndisclosedWith 2 others
  17. Oct
    XingkeyuanVentureUndisclosedWith 2 others
  18. Sept
    ApollomicsUS$4.1MWith 1 other
  19. Sept
    YolTech TherapeuticsSeries B$42MWith 1 other
  20. Sept
    Aureka BiotechnologiesSeries A · US$23MWith 2 others
  21. Jul
    Mocang RobotVentureUndisclosedWith 2 others
  22. Jul
    LTZ TherapeuticsVenture · USUndisclosedWith 4 others
  23. Jun
    Amigo RoboticsVentureUndisclosedSole investor
  24. May
    Collov LabsVenture · US$8.0MWith 2 others
  25. May
    ULS RoboticsSeries B$10MWith 1 other
  26. Mar
    Deep Blue AerospaceSeries B$69MWith 2 others
  27. Mar
    SEEEX TechSeed$14MWith 1 other
  28. Jan
    Cornerstone RoboticsSeries C · HK · Alpha JWC Ventures$70MWith 8 others
  29. 2024

    8 rounds

  30. Oct
    ZhishenhexingPre-seed$1.4MSole investor
  31. Oct
    Qianglian ZhichuangSeries D$14MWith 1 other
  32. Aug
    Weijian TechnologySeries A$17MWith 1 other
  33. Mar
    Tongwei New EnergyVentureUndisclosedWith 1 other
  34. Mar
    Agilis RoboticsSeries A · HK$10MWith 1 other
  35. Feb
    ProfoundBioSeries B · US$112MWith 5 others
  36. Jan
    Niu DajiSeries B$12MSole investor
  37. Jan
    Phanes TherapeuticsVenture · USUndisclosedWith 2 others
  38. 2023

    9 rounds

  39. Sept
    AocaiSeries B$14MSole investor
  40. Aug
    CirCodeVentureUndisclosedWith 1 other
  41. Jul
    Urethane TinglanVentureUndisclosedWith 2 others
  42. Jun
    CellXSeries A · US$6.5MWith 3 others
  43. Jun
    Zhongling XingnengPre-seed$14MSole investor
  44. May
    Mubai KejiVentureUndisclosedSole investor

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration6 named

JNJeremy NeilsonManaging Director of the Issuer's Administrative ManageriFiling they signed
KCKeyi ChenDirectoriForm ADV
OAOzi AmanatIssuer's ManageriFiling they signed
RTRichard ThomsOfficer of the Issuer's Administrative ManageriFiling they signed
RZRui ZhangDirectoriForm ADV
XRXiaochun RenDirectoriForm ADV

We also hold 7 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$1.3Bgross assets of its funds, 2 advisers combinedOct 2026
Exemptreporting adviserventure or small private funds
Legal name
K2 Venture Management Limited
SEC number
CRD 324174

Who they invest alongside

The investors most often in the same rounds as K2VC. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies K2VC put money into.

Quick answers about K2VC

What does K2VC invest in?

K2VC invests most often at Series A and Venture (50% of the rounds on record), in sectors such as Technology, Advanced Manufacturing and New Energy.

How active is K2VC?

175 investments on record, 13 of them in the last 12 months. The most recent was in Apr 2026.

What has K2VC invested in recently?

Its most recent investments on record: Collov Labs (Series A, Apr 2026), Aureka Biotechnologies (Series A, Apr 2026) and Cosmoleap (Venture, Mar 2026).

How big are K2VC's cheques?

The median round it joins is $7.0M.

Does K2VC lead rounds?

Rarely, if at all: none of its 175 investments on record names it as the lead.

Where does K2VC invest?

Most of the companies it backs are in the United States (73%), Hong Kong SAR China (20%) and Singapore (7%).

Is K2VC investing now?

Yes: it is actively investing, with 13 investments in the last 12 months.

Who does K2VC invest alongside?

Most often ZhenFund (17 rounds together), Matrix Partners China (12 rounds together) and Qiming Venture Partners (11 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it